Login / Signup

Monoclonal antibody pairs against SARS-CoV-2 for rapid antigen test development.

Nol SalcedoAnkita ReddyAdam R GomezIrene BoschBobby Brooke Herrera
Published in: PLoS neglected tropical diseases (2022)
Overall, our results suggest that the rapid antigen test is optimized to detect SARS-CoV-2 N during the acute phase of COVID-19. The rapid antigen tests developed in this study are alternative tools for wide scale public health surveillance of COVID-19.
Keyphrases
  • sars cov
  • public health
  • monoclonal antibody
  • respiratory syndrome coronavirus
  • loop mediated isothermal amplification
  • coronavirus disease